Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype
1 clinical trials · Condition
◉ Watch Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype
| Record | Firm | Date |
|---|---|---|
| A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis (NCT05139680) | Pfizer | 2023-03-08 |
Track Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype automatically
Every clearance here is in the API, with alerts when new ones post.